IMPLANTABLE DRUG DELIVERY SYSTEM SEMINAR ON

Slides:



Advertisements
Similar presentations
Quarterly Flexible, Printed Electronics Workshop October 22, 2009 Hosted by SEMI.
Advertisements

Howard E. Gendelman, MD Larson Professor of Medicine and Infectious Diseases Chairman, Department of Pharmacology and Experimental Neuroscience Director,
Properties of Polymers
Pharmacology for Anesthesia I Introduction. What is a Drug?
Biological Membranes.
HOW DO DRUGS GET INTO THE BODY?. WHY BE CONCERNED ABOUT HOW DRUGS GET INTO BODY? Bioavailability - % of dose that gets into body Bioequivalence - similarity.
Reservoir-Membrane Systems
Leachate Collection Systems. Class Objectives  To discuss landfill water balance  To present liner and leachate collection system (LCS) design information.
Copyright © 2005 Brooks/Cole — Thomson Learning Biology, Seventh Edition Solomon Berg Martin Chapter 5 Biological Membranes.
Administration and Absorption of Drugs. Factors that effect the action of a drug 1.Rate of accumulation at its site of action 2.Concentration of the drug.
Lecture 4.
”(Controlled) Drug Release” - what’s the (big) deal???
Controlled Drug Delivery: From Macroformulation to Nanotechnology
Osmotic Pressure-Controlled Gastrointestinal Delivery System
Implants. Implants: Definition: A sterile drug delivery device for subcutaneous implantation having the ability to deliver drug at a controlled rate over.
Silicone Implants Amit Misra Kim Helmer Srikesh Sridharan.
Implants. Implants: Definition: A sterile drug delivery device for subcutaneous implantation having the ability to deliver drug at a controlled rate over.
Responsive Drug Delivery System
Nucleic Acid Engineering and Its Applications Dan Luo, Ph.D. Assistant Professor Department of Biological and Environmental Engineering Cornell University.
1 Controlled Release Introduction and Background.
Introduction to Polymers
Nanotechnology in Drug Delivery for Cancer Current Technologies
DRUG DELIVERY AND TARGETING
NUR HIDAYAH OMAR SITI HAJAR ABU BAKAR ALIA ZULAIKHA MOHD HANIF NUR HIDAYAH OMAR SITI HAJAR ABU BAKAR ALIA ZULAIKHA MOHD HANIF.
Pharmaceutics 2 & 3 صيدلانيات 2&3 Unit / second semester Transdermal drug delivery system.
Methods For Monitoring Transdermal Drug Delivery Analytical/Radio/Nuclear (ARN) Seminar Jivan Yewle Department of Chemistry University of Kentucky.
Presented by.; Dalia Ahmed Noha Mahmoud Supervised by.; Dr. Mona El-Khateb.
Key Terminology 2 Practicum of Health Science – Pharmacy Tech Program.
1.  Drug delivery is the method or process of administering pharmaceutical compound to achieve a therapeutic effect in humans or animals.  Most common.
Biological Properties ISSUES TO ADDRESS... Biomaterials definition Different types of interaction between body and foreign material What are main characteristics.
Liposomes Dr. Aws Alshamsan Department of Pharmaceutics Office: AA87 Tel:
Absorption, Distribution, Metabolism and Elimination (ADME)
Tutorial 1 January 18, 2013.
Vitrasert Ganciclovir Intraocular Implant Reservoir style implant used for the delivery of the anti-viral prodrug ganciclovir. Vitrasert was the first.
Controlled drug delivery Jonathan O’Dwyer John Rasmussen CHEN 641.
DELIVERY OF PROTEINS USING BIODEGRADABLE POLYMERS Mahesh V. Chaubal Guilford Pharmaceuticals Inc. Baltimore, MD 21224
Pharmaceutics I صيدلانيات 1 Unit 2 Route of Drug Administration
Drug Encapsulation Using Supercritical CO₂ By: Maggie L. Plante │ UNH Manchester │ Abstract Supercritical CO₂ can help green the.
Dr. Muslim Suardi, MSi., Apt. Faculty of Pharmacy, University of Andalas.
Principles of Drug Action
Other processing techniques Introduction Fiber pulling Foams Membranes Reactive injection Varnish and paintings Glues Crosslinked resins – Pouring – Compression.
{ Medical Review Doses and Terminology Part 3.  Intended for applying medication to the skin or mucous membrane  Good for dry skin or areas that need.
Controlled (and sometimes local) drug release
Recent Advances In Transdermal Drug Delivery System (TDDS): A Review Singh H.P. 1*, Kaur I. 2, Gullaiya S. 1, Chauhan S Amity Institute of Pharmacy,
DRUG DELIVERY TO RESPIRATORY SYSTEM Department Of Pharmaceutics.
BIOAVAILABILITY AND METHODS OF ENHANCING BIOAVAILABILITY 1 Presented by SHAHEEN BEGUM Hallticket No:10S91R0035 UNDER THE GUIDANCE OF Associate Professor.
Co-cross-linked chitosan hydrogel as carrier for the local delivery of cisplatin. Liposome inclusion. Maria José Moura 1,2, Maria Helena Gil 2, Maria Margarida.
Pharmacology I Session One Pharmacological Principles.
Medical Device Issues Prof. David Woolfson.
Pharmacokinetics and Pharmacodynamics
Route of Drug Administration
Drug Encapsulation Using Supercritical CO₂
Bioabsorbable DES and Biodegradable Polymers – FDA View
Biopharmaceutics of modified release drug products
Chapter 1 Introduction to Biopharmaceutics & Pharmacokinetics
CHEMICAL ENGINEERING PROCESS
Novel Drug Delivery System
Application to Controlled Release of Drugs by Osmotic Pumps
All About Cells Cell Boundaries.
Electro-osmotic drug delivery technology
Pharmacologic Principles – Chapter 2
Emerging Medical Devices for Minimally Invasive Cell Therapy
Drug Delivery Systems Pharmaceutical technology Petra University.
PHT 612 Selected Topics in Drug Delivery I
Fluid Systems.
Concept and System Design of Rate-Controlled Drug Delivery System
Application to Controlled Release of Drugs by Osmotic Pumps
Concepts and System Design for Rate-Controlled Drug Delivery
Biomaterials Dr. Ahmed Moro.
Biomaterials Dr. Ahmed Moro.
Presentation transcript:

IMPLANTABLE DRUG DELIVERY SYSTEM SEMINAR ON Department of Pharmaceutics

DEFINITION Implants are object or material inserted or grafted into the body for therapeutic, diagnostic, or experimental purposes. Implants are also defined as sterile drug product made by compression, inching, or sintering. Implants consist of drug and rate-controlling excipients. EXAMPLE:- 1) Gliadel wafer implants. 2) Zoladex implants.

IDEAL PROPERTIES OF IMPLANTS 1) Environmentally stable. 2) Biostable. 3) Biocompatible. 4) Non toxic and non-carcinogenic. 5) Minimum surface area, smooth texture. 6) Easily removable. 7) Medicament released rate.

Mechanism of drug release from implantable system 1) Diffusion controlled. 2) chemically controlled. 3) swelling controlled. 4) osmotically controlled. 5) magnetic controlled.

implantable drug delivery system an introduction : Implantable drug delivery system an introduction Implantable drug delivery systems are placed completely under the skin — usually in a convenient but inconspicuous location. The patient is aware of only a small bump under the skin. designed to transmit drugs and fluids into the bloodstream without the repeated insertion of needles. well suited to the drug delivery requirements of insulin, steroids, chemotherapeutics, antibiotics, analgesics, total parenteral nutrition, and heparin.

Approaches to design implantable drug delivery systems Controlled drug delivery by diffusion process Polymer membrane permeation- controlled drug delivery Matrix diffusion-controlled drug delivery Microreservior partition-controlled drug delivery system Membrane matrix hybrid-type drug delivery system

b) Controlled drug delivery by activation process. Osmotic pressure Vapor pressure Magnetically Hydration Hydrolysis c) Controlled drug delivery by feed back regulated mechanism. Bioerosion Bioresponce

Controlled drug delivery by diffusion process   1) membrane permeation- controlled drug delivery. Non porous membrane. Micro porous membrane. Semi permeable membrane. drug encapsulated within a drug reservoir. drug release surface is covered by a rate limiting polymeric membrane.

Types of Implants Screw Implants (Left to Right: TPS screw, Ledermann screw, Branemark screw, ITI Bonefit screw)                                                                                                                                Cylinder Implants (Left to Right: IMZ, Integral, Frialit-1 step-cylinder, Frialit-2 step-cylinder)

Advantages: Disadvantages: Invasive Convenience Termination Compliance Potential for controlled release Improved drug delivery Flexibility Disadvantages:  Invasive Termination Danger of device failure  Limited to potent drugs Possibility of adverse reactions Commercial disadvantages

REFERENCES: MODERN PHARMACEUTICS Fourth Edition, Revised and Expanded edited by Gilbert S. Banker University of Iowa, Iowa City, Iowa Christopher, T. Rhodes University of Rhode, Island Kingston, Drug delivery to pulmonary system .(CHAPTER 14) PHARMACEUTICAL PARTICULATE CARRIERS THERAPEUTIC APPLICATIONS Alain Rolland Vol-61 Dekker Publications. (PAGE NO: 31-59) PHYSIOLOGICAL PHARMACEUTICALS BIOLOGICAL BARRIERS TO DRUG ABSORPTION By Clive g.Wilson and Neena Washington. CONTROLLED AND TARGETED DRUG DELIVERY ADVANCES AND CONCEPTS By S.P Vyas And R.P. Khar.